Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking a Director of Regulatory Affairs (US Filing Lead) to drive the preparation and execution of regulatory filings for late-stage oncology programs in the US. The role requires a thorough understanding of oncology drug development, US NDA regulations, and current Health Authority thinking, as well as strong leadership and problem-solving abilities.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines